Erythromycin as a prokinetic agent in infants and children – (05-17-01)



Erythromycin as a prokinetic agent in infants and children

One of these days I may just throw up my hands in despair and give up preaching against the incoming tide. Until then… What we see here is that the pharmaceuticals may be loosing some of their business in this era of reduced antibiotic use so they are looking for another indication for their drug. Save money on R & D…just take one of the side effects of the drug and try to turn it into an indication! Truly amazing. The idea of using an antibiotic to increase motility of the GI tract goes beyond incredulous. How about using probiotics, high fiber and prebiotics (such as insulin and FOS) instead? Much safer and you are actually looking at fixing whatever is causing the decreased transit.

Synergy : Alimentary Pharmacology & Therapeutics 15 (5), 595-603

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Category: Probiotic
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”